PP

Purushotham Pankajaksha Menon

Active Director Designated Partner DIN 10011118
DIN 10011118 First appointment Jul 2022 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Purushotham Pankajaksha Menon

Data last updated:

Purushotham Pankajaksha Menon is a Designated Partner at Scrinium Phytomeds Llp (since 2022). The company operates in Paper.

DIN 10011118
Primary Designation Designated Partner
Industry Paper
First Appointment 14 Jul 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner14 Jul 20222022Active

Board colleagues of Purushotham Pankajaksha Menon

NameDINCompanyDesignation
Murlidhar Pankajaksha Menon10011117Scrinium Phytomeds LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Scrinium Phytomeds Llp
Premium access

Shareholding and investment profile for Purushotham Pankajaksha Menon

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Purushotham Pankajaksha Menon

Purushotham Pankajaksha Menon currently holds 1 directorship: Scrinium Phytomeds Llp (Designated Partner, since 14 Jul 2022).

Purushotham Pankajaksha Menon was first appointed on 14 Jul 2022 as Designated Partner at Scrinium Phytomeds Llp.

The current boards of Purushotham Pankajaksha Menon's companies include Murlidhar Pankajaksha Menon (Scrinium Phytomeds Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available